Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized comparison of tamsulosin prolonged release tablet 0.4 mg vs Harnal capsule 0.2 mg in LUTS associated with BPH
jRCT1080221287Phase 3
- Sponsor
- Astellas Pharma
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tamsulosin in benign prostatic hyperplasia (BPH) and Micturition disorder (2 arms), sponsored by Astellas Pharma.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on jRCT1080221287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221287.